Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Bohai Pharmaceuticals Group, Inc. | Financial_Report.xls |
| EX-31.1 - EXHIBIT 31.1 - Bohai Pharmaceuticals Group, Inc. | exhibit311.htm |
| EX-32.1 - EXHIBIT 32.1 - Bohai Pharmaceuticals Group, Inc. | exhibit321.htm |
| 10-K/A - FORM 10-K/A - Bohai Pharmaceuticals Group, Inc. | bohai10ka00325624xa9c082.htm |
Exhibit 21.1
Subsidiaries of the Registrant
1.
The Company’s wholly owned subsidiary, Chance High International Limited, a British Virgin Islands company (“Chance High”);
2.
Chance High’s wholly owned subsidiary, YantaiNirui Pharmaceutical Co., Ltd., a PRC company (“WOFE”);
3.
the WOFE’s variable interest entity, YantaiBohai Pharmaceuticals Group Co., Ltd., a PRC company (“Bohai”), which is the Company’s initial operating subsidiary; and
4.
WOFE’s wholly owned subsidiary, YantaiTianzheng Pharmaceutical Co., Ltd., a PRC company (“YantaiTianzheng”), which the Company acquired in August 2011 and is the Company’s second operating subsidiary.
1